Blackstone Inc. (BX) had a standout Q4 2024, as indicated by its earnings call transcript. Profits soared due to a rebound in dealmaking, along with an influx of investment activity signalling a recovery in the CRE market. Key metrics exceeded Wall Street estimates, with CEOs dubbing the last quarter as 'one of the best.' Blackstone is now nearing an agreement to buy a midtown New York office tower, possibly exemplifying a global office market recovery. This positive earnings result comes as multiple institutions increase or acquire new positions in Blackstone, despite some others reducing their holdings. There was also a record display of Assets Under Management (AUM) in Q4 but the stock had momentary dips due to real estate and data centre concerns. Blackstone anticipates M&A's increase will boost Collateralized Loan Obligation sales in 2025 and has also made significant movements into the data center and AI markets with the recent acquisition of Potomac Energy Center. A projection of surges in dealmaking lifted Blackstone's Q4 results and is building momentum towards a $5 billion biotech fund. Despite price target reductions, it is still considered undervalued by other investors, which speaks to the complex performance of the quarter.
Blackstone BX News Analytics from Thu, 17 Oct 2024 07:00:00 GMT to Sat, 01 Feb 2025 18:07:52 GMT -
Rating 8
- Innovation 7
- Information 8
- Rumor 9
